Oragenics Inc. short interest in 2019
In 2019, Oragenics Inc.'s disclosed short interest ran from 4.25% of shares outstanding on 15 Jan 2019 to 2.83% on 31 Dec 2019, a change of -1.42 percentage points. The year's high was 5.77% on 31 Jan 2019 and its low 1.57% on 15 Oct 2019, averaging 3.77% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.89 days on 15 Aug 2019. Full history: Oragenics Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2019 in figures
- Start of year
- 4.25% (15 Jan 2019)
- End of year
- 2.83% (31 Dec 2019)
- Change
- -1.42 pp
- High
- 5.77% (31 Jan 2019)
- Low
- 1.57% (15 Oct 2019)
- Average
- 3.77%
- Highest days to cover
- 4.89 (15 Aug 2019)
- SEC filings marked
- 4
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2019 | 4.25% | 1.00 | |
| 31 Jan 2019 | 5.77% | 1.23 | |
| 15 Feb 2019 | 5.63% | 1.67 | |
| 28 Feb 2019 | 5.65% | 2.09 | |
| 15 Mar 2019 | 5.66% | 2.63 | |
| 29 Mar 2019 | 3.20% | 1.00 | 10-K filed |
| 15 Apr 2019 | 2.96% | 1.55 | |
| 30 Apr 2019 | 4.39% | 1.00 | |
| 15 May 2019 | 3.15% | 1.89 | 10-Q filed |
| 31 May 2019 | 3.57% | 1.16 | |
| 14 Jun 2019 | 4.10% | 2.36 | |
| 28 Jun 2019 | 3.95% | 1.72 | |
| 15 Jul 2019 | 4.22% | 3.55 | |
| 31 Jul 2019 | 3.41% | 3.90 | |
| 15 Aug 2019 | 4.29% | 4.89 | 10-Q filed |
| 30 Aug 2019 | 4.08% | 4.06 | |
| 13 Sep 2019 | 3.48% | 1.00 | |
| 30 Sep 2019 | 2.57% | 1.00 | |
| 15 Oct 2019 | 1.57% | 1.73 | |
| 31 Oct 2019 | 2.46% | 3.65 | |
| 15 Nov 2019 | 2.89% | 2.29 | 10-Q filed |
| 29 Nov 2019 | 3.41% | 1.81 | |
| 13 Dec 2019 | 3.07% | 2.02 | |
| 31 Dec 2019 | 2.83% | 3.21 |
See also: Oragenics Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.